Rury L Grisham
Examiner (ID: 4728)
Most Active Art Unit | 2672 |
Art Unit(s) | 2625, 2672 |
Total Applications | 220 |
Issued Applications | 194 |
Pending Applications | 0 |
Abandoned Applications | 26 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18230648
[patent_doc_number] => 20230069642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => PRECISE TEMPLATE-FREE CORRECTION OF BRCA1 MUTATION IN HUMAN CELLS VIA GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 17/819547
[patent_app_country] => US
[patent_app_date] => 2022-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819547 | PRECISE TEMPLATE-FREE CORRECTION OF BRCA1 MUTATION IN HUMAN CELLS VIA GENOME EDITING | Aug 11, 2022 | Pending |
Array
(
[id] => 17982830
[patent_doc_number] => 20220348866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => MODIFIED INDUCED PLURIPOTENT STEM CELL (iPSC) DERIVED MICROGLIA FOR THE TREATMENT OF BRAIN CANCER
[patent_app_type] => utility
[patent_app_number] => 17/720753
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17720753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/720753 | MODIFIED INDUCED PLURIPOTENT STEM CELL (iPSC) DERIVED MICROGLIA FOR THE TREATMENT OF BRAIN CANCER | Apr 13, 2022 | Pending |
Array
(
[id] => 17883006
[patent_doc_number] => 20220298483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => METHOD AND COMPOSITION FOR CHONDROGENESIS
[patent_app_type] => utility
[patent_app_number] => 17/697168
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697168
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697168 | METHOD AND COMPOSITION FOR CHONDROGENESIS | Mar 16, 2022 | Abandoned |
Array
(
[id] => 17831456
[patent_doc_number] => 20220268760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => ATRIAL CARDIAC MICROTISSUES FOR CHAMBER-SPECIFIC ARRHYTHMOGENIC TOXICITY RESPONSES
[patent_app_type] => utility
[patent_app_number] => 17/675895
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675895 | ATRIAL CARDIAC MICROTISSUES FOR CHAMBER-SPECIFIC ARRHYTHMOGENIC TOXICITY RESPONSES | Feb 17, 2022 | Pending |
Array
(
[id] => 17838059
[patent_doc_number] => 20220275364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/588038
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588038 | VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME | Jan 27, 2022 | Pending |
Array
(
[id] => 17733296
[patent_doc_number] => 20220218755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => EXTRACELLULAR VESICLES AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 17/572164
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572164
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572164 | EXTRACELLULAR VESICLES AND THEIR USES | Jan 9, 2022 | Pending |
Array
(
[id] => 18838560
[patent_doc_number] => 11846627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Method and composition for sorting out of cell comprising a modified gene
[patent_app_type] => utility
[patent_app_number] => 17/568032
[patent_app_country] => US
[patent_app_date] => 2022-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17114
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17568032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/568032 | Method and composition for sorting out of cell comprising a modified gene | Jan 3, 2022 | Issued |
Array
(
[id] => 17684873
[patent_doc_number] => 20220192165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => NON-HUMAN ANIMALS HAVING A HUMANIZED TSLP GENE, A HUMANIZED TSLP RECEPTOR GENE, AND/OR A HUMANIZED IL7RA GENE
[patent_app_type] => utility
[patent_app_number] => 17/555550
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555550 | NON-HUMAN ANIMALS HAVING A HUMANIZED TSLP GENE, A HUMANIZED TSLP RECEPTOR GENE, AND/OR A HUMANIZED IL7RA GENE | Dec 19, 2021 | Pending |
Array
(
[id] => 17673085
[patent_doc_number] => 20220186252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => ADENO ASSOCIATED VIRAL VECTOR DELIVERY OF ANTIBODIES FOR THE TREATMENT OF DISEASE MEDIATED BY DYSREGULATED PLASMA KALLIKREIN
[patent_app_type] => utility
[patent_app_number] => 17/552174
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552174
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552174 | ADENO ASSOCIATED VIRAL VECTOR DELIVERY OF ANTIBODIES FOR THE TREATMENT OF DISEASE MEDIATED BY DYSREGULATED PLASMA KALLIKREIN | Dec 14, 2021 | Pending |
Array
(
[id] => 19166035
[patent_doc_number] => 11981925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Decidual placental mesenchymal stem cell and the use of the cell for preparing pharmaceutical compositions for promoting angiogenesis
[patent_app_type] => utility
[patent_app_number] => 17/539253
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 2770
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/539253 | Decidual placental mesenchymal stem cell and the use of the cell for preparing pharmaceutical compositions for promoting angiogenesis | Nov 30, 2021 | Issued |
Array
(
[id] => 17719050
[patent_doc_number] => 20220211769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => THERAPEUTIC METHODS AND COMPOSITIONS UTILIZING STROMAL VASCULAR FRACTION DERIVED FROM ADIPOSE TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/525312
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525312 | THERAPEUTIC METHODS AND COMPOSITIONS UTILIZING STROMAL VASCULAR FRACTION DERIVED FROM ADIPOSE TISSUE | Nov 11, 2021 | Pending |
Array
(
[id] => 17518621
[patent_doc_number] => 20220104469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => RODENT ANIMALS EXPRESSING HUMAN CR1
[patent_app_type] => utility
[patent_app_number] => 17/490449
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17490449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/490449 | RODENT ANIMALS EXPRESSING HUMAN CR1 | Sep 29, 2021 | Pending |
Array
(
[id] => 17505152
[patent_doc_number] => 20220098254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => NEUROD1 and DLX2 VECTOR
[patent_app_type] => utility
[patent_app_number] => 17/487169
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17487169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/487169 | NEUROD1 and DLX2 VECTOR | Sep 27, 2021 | Pending |
Array
(
[id] => 17482508
[patent_doc_number] => 20220090012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE
[patent_app_type] => utility
[patent_app_number] => 17/483100
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -77
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483100 | GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE | Sep 22, 2021 | Pending |
Array
(
[id] => 17444087
[patent_doc_number] => 20220064592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => CELL MICROSHEET, SYRINGE CONTAINING THE CELL MICROSHEET, AND PRODUCTION AND USE OF THE CELL MICROSHEET
[patent_app_type] => utility
[patent_app_number] => 17/465425
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465425 | CELL MICROSHEET, SYRINGE CONTAINING THE CELL MICROSHEET, AND PRODUCTION AND USE OF THE CELL MICROSHEET | Sep 1, 2021 | Pending |
Array
(
[id] => 17444161
[patent_doc_number] => 20220064666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => SYNTHETIC MAMMALIAN SIGNALING CIRCUITS FOR ROBUST CELL POPULATION CONTROL
[patent_app_type] => utility
[patent_app_number] => 17/460120
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460120 | Synthetic mammalian signaling circuits for robust cell population control | Aug 26, 2021 | Issued |
Array
(
[id] => 17397272
[patent_doc_number] => 20220039362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => HUMANIZED MOUSE MODEL SUSCEPTIBLE TO EMERGING CORONAVIRUSES
[patent_app_type] => utility
[patent_app_number] => 17/409265
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/409265 | HUMANIZED MOUSE MODEL SUSCEPTIBLE TO EMERGING CORONAVIRUSES | Aug 22, 2021 | Pending |
Array
(
[id] => 17428770
[patent_doc_number] => 20220056478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/406723
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/406723 | ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME | Aug 18, 2021 | Pending |
Array
(
[id] => 17357122
[patent_doc_number] => 20220017918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Synthesis of Non-Native Proteins in Bombyx Mori by Modifying Sericin Expression
[patent_app_type] => utility
[patent_app_number] => 17/377318
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/377318 | Synthesis of Non-Native Proteins in Bombyx Mori by Modifying Sericin Expression | Jul 14, 2021 | Pending |
Array
(
[id] => 17368332
[patent_doc_number] => 20220023384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => MYBPC3 POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/371017
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371017
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371017 | MYBPC3 POLYPEPTIDES AND USES THEREOF | Jul 7, 2021 | Pending |